AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 161,532 | 84,898 | 68,342 | 79,640 |
| Receivables | 894 | 16,158 | 1,668 | 270 |
| Other current assets | 397 | 208 | 107 | 2,670 |
| TOTAL | $163,675 | $105,666 | $73,330 | $82,580 |
| Non-Current Assets | ||||
| PPE Net | 938 | 688 | 652 | 2,470 |
| Investments And Advances | 87 | 88 | 86 | 80 |
| TOTAL | $1,025 | $776 | $737 | $2,550 |
| Total Assets | $164,700 | $106,442 | $74,067 | $83,190 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 2,903 | 2,705 | 1,001 | 1,780 |
| Accrued Expenses | 6,937 | 4,863 | 3,755 | 4,510 |
| Other current liabilities | 109 | 109 | N/A | 40 |
| TOTAL | $11,287 | $9,836 | $5,917 | $6,340 |
| Non-Current Liabilities | ||||
| Deferred Revenues | 1,339 | 2,158 | 1,161 | N/A |
| Other Non-Current Liabilities | 3,549 | 3,294 | 3,012 | 2,900 |
| TOTAL | $3,549 | $3,294 | $3,012 | $2,900 |
| Total Liabilities | $14,836 | $13,130 | $8,929 | $9,250 |
| Shareholders' Equity | ||||
| Common Shares | 1,154 | 1,018 | 935 | 960 |
| Retained earnings | -43,985 | -34,860 | -47,034 | -42,020 |
| TOTAL | $149,864 | $93,313 | $65,138 | $73,940 |
| Total Liabilities And Equity | $164,700 | $106,442 | $74,067 | $83,190 |